Literature DB >> 28794166

PROPERTIES OF THE TRPV4 AGONIST GSK1016790A AND the TRPV4 ANTAGONIST GSK2193874.

Kevin S Thorneloe1, Mui Cheung1, Dennis A Holt1, Robert N Willette1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28794166     DOI： 10.1152/physrev.00019.2017

Source DB:  PubMed          Journal:  Physiol Rev        ISSN： 0031-9333            Impact factor:   37.312


× No keyword cloud information.
  3 in total

1.  Systemic application of the transient receptor potential vanilloid-type 4 antagonist GSK2193874 induces tail vasodilation in a mouse model of thermoregulation.

Authors:  Fiona O'Brien; Caroline A Staunton; Richard Barrett-Jolley
Journal:  Biol Lett       Date:  2022-06-15       Impact factor: 3.812

2.  Differential modulation of transendothelial electrical resistance by TRPV4 agonists is mediated by apoptosis and/or necrosis.

Authors:  N Pairet; S Mang; T Kiechle; N Laufhäger; P Dietl; D J Lamb
Journal:  Biochem Biophys Rep       Date:  2019-09-19

3.  TRPV4 Stimulation Level Regulates Ca2+-Dependent Control of Human Corneal Endothelial Cell Viability and Survival.

Authors:  Jennifer Donau; Huan Luo; Iiris Virta; Annett Skupin; Margarita Pushina; Jana Loeffler; Frauke V Haertel; Anupam Das; Thomas Kurth; Michael Gerlach; Dirk Lindemann; Peter S Reinach; Stefan Mergler; Monika Valtink
Journal:  Membranes (Basel)       Date:  2022-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.